tiprankstipranks
Advertisement
Advertisement

PERCF Stock Latest News

Percheron Therapeutics Updates Market on Lapse of 600,000 Options
Company AnnouncementsPercheron Therapeutics Updates Market on Lapse of 600,000 Options
10d ago
Percheron secures funding and key conference slots to advance HMBD-002 into phase II
PremiumCompany Announcements
Percheron secures funding and key conference slots to advance HMBD-002 into phase II
11d ago
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
PremiumCompany Announcements
Percheron Therapeutics Issues 131 Million Unquoted Options at $0.01 Exercise Price
19d ago
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
PremiumCompany Announcements
Percheron Therapeutics Seeks ASX Quotation for 262.9 Million New Shares
19d ago
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
PremiumCompany Announcements
Percheron’s VISTA-Targeting Cancer Drug Clears Key Phase I Safety Hurdle
20d ago
Percheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
PremiumCompany AnnouncementsPercheron Therapeutics Updates ASX Filing on Unquoted Equity Securities
26d ago
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
Premium
Company Announcements
Percheron Therapeutics Corrects ASX Filing on Unquoted Equity Securities
26d ago
Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028
Premium
Company Announcements
Percheron Therapeutics Issues 27.5 Million Unquoted Options Expiring in 2028
26d ago
Percheron Therapeutics Issues 50 Million Unquoted Options Expiring in 2028
PremiumCompany Announcements
Percheron Therapeutics Issues 50 Million Unquoted Options Expiring in 2028
26d ago
Percheron Director Increases Stake Through Entitlement Offer
PremiumCompany Announcements
Percheron Director Increases Stake Through Entitlement Offer
26d ago
Percheron Therapeutics Issues 86 Million Unquoted Options Expiring 2028
PremiumCompany Announcements
Percheron Therapeutics Issues 86 Million Unquoted Options Expiring 2028
26d ago
Percheron Therapeutics Seeks ASX Quotation for 172 Million New Shares
PremiumCompany Announcements
Percheron Therapeutics Seeks ASX Quotation for 172 Million New Shares
26d ago
Percheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
PremiumCompany AnnouncementsPercheron Raises $2.2m to Advance HMBD-002 Towards Phase II Trial
27d ago
Percheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
Premium
Company Announcements
Percheron Sets Closing Date for Entitlement Offer to Fund Therapeutic Pipeline
1M ago
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
Premium
Company Announcements
Percheron to Showcase New HMBD-002 Cancer Data at ASCO 2026
1M ago
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
PremiumCompany Announcements
Percheron Therapeutics Launches Discounted Entitlement Offer, Excludes Overseas Holders
2M ago
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
PremiumCompany Announcements
Percheron Therapeutics Launches Non-Renounceable Entitlement Offer With Free-Attaching Options
2M ago
Percheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
PremiumCompany Announcements
Percheron Therapeutics Launches Discounted Entitlement and Shortfall Offer
2M ago
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
PremiumCompany Announcements
Percheron Therapeutics Plans Issue of 50 Million Unquoted Options
2M ago
Percheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
PremiumCompany AnnouncementsPercheron Therapeutics Plans Large Pro Rata Capital Raising on ASX
2M ago
Percheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
Premium
Company Announcements
Percheron Updates Timetable for $2.2m Entitlement Offer Ahead of 2026 Trials
2M ago
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
Premium
Company Announcements
Percheron Therapeutics Launches Pro Rata Rights Offer at Discounted Issue Price
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >